298! The Trial is OVER!
CEL-SCI announced that their nearly 10 year trial has finally ended. The 298th event (death) recently occurred. May the ones who have perished to this terrible disease find peace.
We expect a few things to occur:
Why is a small Biotech with limited cash resources hiring manufacturing positions? Why would they incur the costs to hire, train and pay new employees at this juncture?
Per the recent Zacks article, they have already hired 7 employees since 1/1/20 and are now looking to add 4 more!
This is not normal...This is BULLISH!!!!!
In the PR accompanying the 10-Q, the CEO, Geert Kersten, dropped a BOMB!
"We are therefore preparing for commercial scale production of Multikine at our manufacturing facility,” stated CEL-SCI CEO, Geert Kersten.
Press Release from 3/23:
Press Release from 3/9:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." - Peter Lynch
On 2/26, 6 insiders purchased shares after the attempted "take down" by those Nasty Shorts!
On 1/13, Geert buys another $50K! (hint hint. wink wink)
On 10/25, Geert bought another $25K!
On 9/4, the Geert and 2 others purchased another $57K.
On 6/3, Geert bought MORE! He bought another $25K
On 5/7, Geert "purchased another $100,000 worth of restricted CEL-SCI stock at $6.86 directly from the Company at the full market price. Several others from our senior management team and one member of the Board of Directors have joined Geert and purchased another $110,000 worth of CEL-SCI stock on the same terms. "
Furthermore, on 5/21 Peter Young bought another $10K on the open market.
All Insider Transactions can be seen here.
On February 4th, CNBC's Jim Cramer AGAIN gives another ***BUY*** for CVM!!!
"This is one I'm in favor of, even up here."
This is the second time in 4 months!
Why has CEL-SCI contracted with The Petrizzo Group to lobby the FDA/US Government about "FDA approval issues of innovative drug therapies"?
Why spend $150K when cash flow is low?
They lobbied the U.S. Senate, the U.S. House of Reps, the FDA, the Office of Management and Budget and Health & Human Services.
This ain't cheap. They have spent $50K for the last 3 quarters. Latest LD-2 form here.
On 9/25, Ergomed released their Interim financial results. In this presentation, they state the following:
96% complete...not 95% or "First Half of 2019" (like their prior presentation), but 96%. Why not 95%?
This implies we are at 286 Events! FOSCO is RIGHT!!!!
******BUT WAIT!!! Shortly after posting this all over the internet, the Interim Presentation was REMOVED and UPDATED. It no longer mentions "96% Complete".
Don't worry, your pal Sushi kept a copy here!
Why did they remove 96%? Because they fucked up and accidentally released CONFIDENTIAL info. That's why!
READ THE AMAZING ARTICLE BELOW
Copyright © 2019 Killcvmshorts - All Rights Reserved. NOT AFFILIATED WITH CEL-SCI IN ANY CAPACITY! THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. WEBSITE CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS. THIS NUT JOB HAS SHARES OF CVM AND IS LONG. THIS NUT JOB ISNT BEING COMPENSATED FOR THIS SITE. THIS NUT JOB NEVER HAS BEEN COMPENSATED FOR ANY OF MY DUE DILIGENCE OR WORK RELATED TO CVM. ALL THESE OPINIONS ARE OF A NUT JOB.
Powered by GoDaddy Website Builder